RBM17 and acute myeloid leukemia: We found that overexpression of EIF4A2 partially reversed the adverse effects of RBM17 knockdown on AML cell apoptosis, cell growth (Fig. 7f, Supplementary Fig. 5a) and partially rescued AML cell differentiation induced by RBM17 knockdown (Fig. 7g).